The action of ginsenoside Rg1 in patients with carotid atherosclerosis: a controlled clinical trial
Patients with carotid atherosclerotic plaques, adding ginsenoside Rg1 to standard therapy reduced the number and volume of carotid plaques. It improved quality of life, decreased specific inflammatory markers, and enhanced blood pressure control and Insulin Resistance (IR). These suggest ginsenoside Rg1 may have clinical value in the future management of carotid atherosclerosis.
Authors
- Yinsong Dong
- Fang Xu (ORCID: https://orcid.org/0000-0002-0895-3071)
- Xuan Ma (ORCID: https://orcid.org/0000-0001-9387-8776)
- Man Zhang
- Li Zhang (ORCID: https://orcid.org/0000-0002-3617-2627)
- Xu He (ORCID: https://orcid.org/0000-0002-1670-0015)
- Shilei Liu (ORCID: https://orcid.org/0000-0003-2976-6256)
- Yan Li (ORCID: https://orcid.org/0000-0002-5921-7752)
- Junzi Wu
Institutions
- Yunnan University (CN)
- First People's Hospital of Yunnan Province (CN)
- Yunnan Environmental Protection Bureau (CN)
- Yunnan University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-09-02
- DOI
- https://doi.org/10.3389/fphar.2025.1638359
- Citations
- 1
- Primary Topic
- Lipid metabolism and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.39